1. Home
  2. PAXS vs EMBC Comparison

PAXS vs EMBC Comparison

Compare PAXS & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAXS
  • EMBC
  • Stock Information
  • Founded
  • PAXS 2021
  • EMBC 1924
  • Country
  • PAXS United States
  • EMBC United States
  • Employees
  • PAXS N/A
  • EMBC N/A
  • Industry
  • PAXS Investment Managers
  • EMBC Medical/Dental Instruments
  • Sector
  • PAXS Finance
  • EMBC Health Care
  • Exchange
  • PAXS Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • PAXS 717.7M
  • EMBC 719.1M
  • IPO Year
  • PAXS N/A
  • EMBC N/A
  • Fundamental
  • Price
  • PAXS $15.00
  • EMBC $11.34
  • Analyst Decision
  • PAXS
  • EMBC Hold
  • Analyst Count
  • PAXS 0
  • EMBC 3
  • Target Price
  • PAXS N/A
  • EMBC $17.67
  • AVG Volume (30 Days)
  • PAXS 195.0K
  • EMBC 655.8K
  • Earning Date
  • PAXS 01-01-0001
  • EMBC 05-08-2025
  • Dividend Yield
  • PAXS 11.72%
  • EMBC 5.39%
  • EPS Growth
  • PAXS N/A
  • EMBC 2.96
  • EPS
  • PAXS N/A
  • EMBC 0.99
  • Revenue
  • PAXS N/A
  • EMBC $1,107,700,000.00
  • Revenue This Year
  • PAXS N/A
  • EMBC N/A
  • Revenue Next Year
  • PAXS N/A
  • EMBC $0.99
  • P/E Ratio
  • PAXS N/A
  • EMBC $11.45
  • Revenue Growth
  • PAXS N/A
  • EMBC N/A
  • 52 Week Low
  • PAXS $12.57
  • EMBC $10.00
  • 52 Week High
  • PAXS $15.93
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • PAXS 43.34
  • EMBC 35.88
  • Support Level
  • PAXS $14.14
  • EMBC $11.58
  • Resistance Level
  • PAXS $15.09
  • EMBC $12.58
  • Average True Range (ATR)
  • PAXS 0.55
  • EMBC 0.77
  • MACD
  • PAXS -0.03
  • EMBC 0.01
  • Stochastic Oscillator
  • PAXS 55.02
  • EMBC 14.75

About PAXS PIMCO Access Income Fund of Beneficial Interest

PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: